MS
CVS icon

Maven Securities’s CVS Health CVS Stock Holding History

Maven Securities’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-28,790
Closed -$1.72M – 827
2024
Q4 		$1.29M Sell
28,790
-7,223
-20% -$405K 0.03% 371
2024
Q3 		$2.26M Sell
36,013
-6,047
-14% -$353K 0.04% 325
2024
Q2 		$2.48M Buy
+42,060
New +$2.63M 0.06% 324
2023
Q4 		– Sell
-6,278
Closed -$447K – 976
2023
Q3 		$438K Buy
+6,278
New +$445K 0.01% 851
2022
Q4 		– Sell
-6,333
Closed -$611K – 893
2022
Q3 		$604K Buy
+6,333
New +$627K 0.01% 724
2022
Q2 		– Sell
-3,245
Closed -$317K – 927
2022
Q1 		$328K Buy
+3,245
New +$341K 0.01% 675
2021
Q4 		– Sell
-4,028
Closed -$372K – 889
2021
Q3 		$342K Sell
4,028
-4,871
-55% -$408K 0.01% 796
2021
Q2 		$743K Buy
+8,899
New +$729K 0.03% 528

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Maven Securities's CVS Position: Q1 2025 in Review

Maven Securities sold out of CVS Health (CVS) in Q1 2025, closing a stake of 28,790 shares — an estimated $1.72M sold.

Maven Securities first reported a position in CVS in Q2 2021 and held it in 8 quarters. The position peaked at $2.48M in Q2 2024. 1,752 funds tracked by Wall St. Rank hold CVS as of Q1 2025.

  • Maven Securities reported no remaining CVS Health position as of Q1 2025 after selling out during the quarter.
  • Maven Securities sold 28,790 CVS Health shares in Q1 2025, an estimated $1.72M.
  • Maven Securities first reported a position in CVS Health in Q2 2021 and held it in 8 quarters.
  • Maven Securities's CVS Health position peaked at $2.48M in Q2 2024.
  • 1,752 funds tracked by Wall St. Rank held CVS Health as of Q1 2025.

Based on Maven Securities's 13F filing for Q1 2025, filed 14 May 2025.